ArticleThe lancet. HIV2020
More evidence for dolutegravir as first-line ART for all.
Janne Estill et al.PubMed ↗Publisher ↗
No numbers read from the abstract.
3 papers cite it
this papercites it
ArticleThe lancet. HIV2020
Janne Estill et al.PubMed ↗Publisher ↗
No numbers read from the abstract.